Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05309395 · ClinicalTrials.gov registry record · Phase 3

Food Prescriptions to Promote Affordable Diets

A Phase 3 study of Overweight and Obesity and Diet, Healthy, sponsored by Kaiser Permanente.

Recruiting
Registry status
Phase 3
Development phase
720
Enrollment target
1
Study location

NCT05309395 is a Phase 3 study of Overweight and Obesity and Diet, Healthy that is actively recruiting participants, run by Kaiser Permanente. The registered enrollment target is 720 participants, above the 222-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (224% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05309395, a Phase 3 study of Overweight and Obesity and Diet, Healthy, is actively recruiting participants, sponsored by Kaiser Permanente.

RECRUITING
Registry status
Phase 3
Development phase
720 participants
Enrollment target
1
Study location

Study Summary

This is an Randomized controlled trial (RCT) to assess the impact of meal planning and affordable grocery delivery on weight loss, dietary quality and health on members of multigenerational Latino households.

Interventions

  • COMBINATION_PRODUCT FoodRx

Study Locations (1)

California

  • Kaiser Permanente - Pasadena

Trial Details

FieldValue
Enrollment Target 720 participants
Start Date 2021-08-21
Est. Completion 2027-06-01
Phase Phase 3

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT05309395

The ClinicalTrials.gov registry entry for NCT05309395 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 720 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 222-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (224% higher). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Overweight and Obesity appearing as the primary indexed condition, and to 1 intervention - of which FoodRx is the first listed.

NCT05309395 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05309395 about?

NCT05309395 is a clinical study titled "Food Prescriptions to Promote Affordable Diets". This is an Randomized controlled trial (RCT) to assess the impact of meal planning and affordable grocery delivery on weight loss, dietary quality and health on members of multigenerational Latino households.

What is the current status of trial NCT05309395?

This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 720 participants. The study started on 2021-08-21. Estimated completion is 2027-06-01.

What conditions does trial NCT05309395 study?

This clinical trial studies the following conditions: Overweight and Obesity, Diet, Healthy.

What interventions are being tested in trial NCT05309395?

The interventions under investigation include: FoodRx (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT05309395?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05309395 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.